Atlas Trials

Ph2 Nab-paclitaxel With Gemcitabine to Determine Efficacy in Advanced Non-squamous NSCLC.

Clinical trial NCT02405910 · WITHDRAWN

Trial details

NCT number
NCT02405910
Sponsor
West Virginia University
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer
Start date
2015-03-15
Primary completion
2017-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.